Wordt geladen...
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors
BACKGROUND: New, more effective strategies are needed to treat highly aggressive neuroblastoma. Our laboratory has previously shown that full-length Secreted Protein Acidic and Rich in Cysteine (SPARC) and a SPARC peptide corresponding to the follistatin domain of the protein (FS-E) potently block a...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2010
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2895596/ https://ncbi.nlm.nih.gov/pubmed/20525313 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-9-138 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|